Radiation Oncology Practice Corporation - North
Kansas City, Missouri, United States
Doctor in Kansas City, Missouri
4323 Wornall Rd, Kansas City, MO 64111
About Radiation Oncology Practice Corporation - North
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
16
GOG Foundation
1
Gynecologic Oncology Group
1
Clinical Trials at Radiation Oncology Practice Corporation - North
During the past decade, Radiation Oncology Practice Corporation - North conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 9 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
2002-04-01
2014-02-01
Completed
58
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
2005-01-01
2012-01-20
Completed
61
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
2004-08-15
Active, not recruiting
406
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
2004-12-15
Active, not recruiting
460
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
2006-02-01
2010-08-01
Terminated
402
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2005-09-01
2015-04-01
Completed
1,873
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Radiation Oncology Practice Corporation - North"
#1 collaborator was "NCIC Clinical Trials Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator and "Gynecologic Oncology Group" with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Radiation Oncology Practice Corporation - North
According to Clinical.Site data, the most researched conditions in "Radiation Oncology Practice Corporation - North" are
"Cervical Adenocarcinoma" (2 trials), "Clear Cell Renal Cell Carcinoma" (2 trials), "Recurrent Uterine Corpus Carcinoma" (2 trials), "Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome" (1 trials) and "Adenocarcinoma of the Colon" (1 trials). Many other conditions were trialed in "Radiation Oncology Practice Corporation - North" in a lesser frequency.
Clinical Trials Intervention Types at Radiation Oncology Practice Corporation - North
Most popular intervention types in "Radiation Oncology Practice Corporation - North" are "Drug" (17 trials), "Other" (11 trials), "Biological" (8 trials), "Radiation" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Quality-of-Life Assessment" (4 trials), "Bevacizumab" (3 trials), "Cisplatin" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Radiation Oncology Practice Corporation - North
The vast majority of trials in "Radiation Oncology Practice Corporation - North" are
10 trials for "All" genders and 8 trials for "Female" genders.
Clinical Trials Status at Radiation Oncology Practice Corporation - North
Currently, there are NaN active trials in "Radiation Oncology Practice Corporation - North".
undefined are not yet recruiting,
undefined are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Radiation Oncology Practice Corporation - North,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Radiation Oncology Practice Corporation - North, 0 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".